Cardiac monitoring

MediLynx Cardiac Monitoring Awarded Patent for Remote ECG Monitoring With Full Disclosure ECG Signal Transmission

Retrieved on: 
Thursday, May 16, 2019

PLANO, Texas, May 16, 2019 /PRNewswire/ --MediLynx Cardiac Monitoring LLC today announced the company has received a patent for its PocketECG full-disclosure ECG monitoring and transmission technology with patient symptomatic event reporting for remote cardiac monitoring.

Key Points: 
  • PLANO, Texas, May 16, 2019 /PRNewswire/ --MediLynx Cardiac Monitoring LLC today announced the company has received a patent for its PocketECG full-disclosure ECG monitoring and transmission technology with patient symptomatic event reporting for remote cardiac monitoring.
  • The patent covers use of the technology and methodology for arrhythmia monitoring and for remote or home-based cardiac rehabilitation.
  • The PocketECG integrated arrhythmia monitoring system is cleared by the Food and Drug Administration for ambulatory cardiac monitoring.
  • MediLynx Cardiac Monitoring LLC, is a leader in cardiac monitoring, delivering best-in-class cardiac diagnostic solutions and service to enable the best possible care for patients.

Duration of External ECG Monitoring is Critical to Detecting Atrial Fibrillation

Retrieved on: 
Thursday, May 9, 2019

MINNEAPOLIS, May 9, 2019 /PRNewswire/ -- Preventice Solutions announced today the presentation of data showing the critical impact the length of the monitoring period has when using ambulatory remote ECG monitoring to detect atrial fibrillation (AF).

Key Points: 
  • MINNEAPOLIS, May 9, 2019 /PRNewswire/ -- Preventice Solutions announced today the presentation of data showing the critical impact the length of the monitoring period has when using ambulatory remote ECG monitoring to detect atrial fibrillation (AF).
  • This truncated duration of monitoring is associated with "missed" AF in more than 10 percent of patients, many of whom have greater than one hour of AF.
  • In the study, data was evaluated from 25,457 randomly selected patients who had undergone monitoring with the BodyGuardian Remote Monitoring System.
  • "We have developed the BodyGuardian Remote Monitoring System to address the critical needs of patients and physicians.

Bardy Diagnostics™ Selected as Winner of the Frost & Sullivan Award for Technology Innovation in Remote Cardiac Monitoring

Retrieved on: 
Tuesday, May 7, 2019

Frost & Sullivan specifically praisedthe CAMpatch'spioneering advancements in engineering and design that have quickly become theindustry standardfor highfidelity ECG datasets includingaccurate and clearP-wave detection and recording.

Key Points: 
  • Frost & Sullivan specifically praisedthe CAMpatch'spioneering advancements in engineering and design that have quickly become theindustry standardfor highfidelity ECG datasets includingaccurate and clearP-wave detection and recording.
  • "Overall, BardyDx's thought leadership, unparalleled innovation, and disruptive potential have positioned it for greater adoption in the cardiac monitoring market," said Kamaljit Behera, Industry Analyst at Frost & Sullivan.
  • In addition, BardyDx was selected as the winner of the 2018 Fierce Innovation Life Sciences Award for Medical Device Innovation from the leading industry publisher of FierceBiotech& FiercePharma.
  • Bardy Diagnostics, Inc. is an innovator in digital health and remote patient monitoring, with a focus on providing diagnostically-accurate and patient-friendly cardiac patch and other monitors to the industry.

VivaQuant Receives FDA 510(k) Clearance for its RX-1 Rhythm ExpressTM Arrhythmia Device

Retrieved on: 
Tuesday, April 30, 2019

VivaQuant, a digital health company with powerful technology to accurately and efficiently identify and report cardiac arrhythmias, has received FDA clearance for its RX-1 wearable device.

Key Points: 
  • VivaQuant, a digital health company with powerful technology to accurately and efficiently identify and report cardiac arrhythmias, has received FDA clearance for its RX-1 wearable device.
  • RX-1 employs VivaQuants patented wavelet-based analytics and embedded artificial intelligence to extract information more quickly, accurately, and efficiently than traditional technologies.
  • VivaQuants cardiac arrhythmia diagnostic products are sold under the Rhythm ExpressTM brand.
  • VivaQuant is a digital health company using its Rhythm ExpressTM platform to analyze and report information from continuous ambulatory ECG recordings.

Global Patient Monitoring Devices Market to 2022 - A $30.7 Billion Opportunity, Growing at a CAGR of 8.2% - ResearchAndMarkets.com

Retrieved on: 
Thursday, April 4, 2019

The patient monitoring devices market is segmented by type into fetal and neonatal monitoring devices, vital parameter monitoring devices and equipment, weight monitoring and body temperature monitoring devices and equipment, and remote patient monitoring devices and equipment.

Key Points: 
  • The patient monitoring devices market is segmented by type into fetal and neonatal monitoring devices, vital parameter monitoring devices and equipment, weight monitoring and body temperature monitoring devices and equipment, and remote patient monitoring devices and equipment.
  • The fetal and neonatal monitoring devices market is further segmented into neonatal monitoring devices and fetal monitoring devices.
  • The vital parameter monitoring devices and equipment market is further segmented into multiparameter monitoring devices, cardiac monitoring devices, respiratory monitoring devices, neuromonitoring devices, and hemodynamic monitoring devices.
  • The weight monitoring and body temperature monitoring devices and equipment market is further segmented into weight monitoring devices and temperature monitoring devices.

Patient Monitoring Devices Global Market Opportunities And Strategies To 2022

Retrieved on: 
Wednesday, April 3, 2019

NEW YORK, April 2, 2019 /PRNewswire/ -- Patient Monitoring Devices Global Market Opportunities And Strategies To 2022 report provides the strategists, marketers and senior management with the critical information they need to assess the global patient monitoring devices market.

Key Points: 
  • NEW YORK, April 2, 2019 /PRNewswire/ -- Patient Monitoring Devices Global Market Opportunities And Strategies To 2022 report provides the strategists, marketers and senior management with the critical information they need to assess the global patient monitoring devices market.
  • Market Characteristics The market characteristics section of the report defines and explains the patient monitoring devices market.
  • Global Macro Comparison The global patient monitoring devices market comparison with macro-economic factors gives the patient monitoring devices market size, percentage of GDP, and average patient monitoring devices market expenditure.
  • By Type: Fetal And Neonatal Monitoring Devices is segmented into Fetal Monitoring Devices, Neonatal monitoring devices, Multiparameter Monitoring Devices, Cardiac Monitoring Devices, Respiratory Monitoring Devices
    Vital Parameter Monitoring Devices And Equipment is segmented into Neuromonitoring Devices, Hemodynamic Monitoring Devices
    Weight Monitoring And Body Temperature Monitoring Devices And Equipment is segmented into Weight Monitoring Devices, Temperature Monitoring Devices
    Remote Patient Monitoring Devices And Equipment is segmented into Vital Parameter Monitors and Others, Cardiac Monitors, Respiratory Monitors, Hematological Monitors
    Time series: Five years historic and forecast.

United States Wireless Ambulatory Telemetry Market Report 2019-2025 - ResearchAndMarkets.com

Retrieved on: 
Monday, March 25, 2019

The "Wireless Ambulatory Telemetry Market Report - United States - 2019-2025" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Wireless Ambulatory Telemetry Market Report - United States - 2019-2025" report has been added to ResearchAndMarkets.com's offering.
  • Over the forecast period, the total market will continue grow steadily alongside the interest in investing in patient-worn monitors across unmonitored lower-acuity hospital settings.
  • The telemetry monitoring device market includes wireless patient-worn monitors and the associated wireless central stations.
  • Wireless ambulatory telemetry is most commonly found in cardiac care areas, including stroke units, coronary care units and step-down units, where the ability for patients to be mobile is especially important.

Global Single Lead ECG Equipment Market by End-use, Indication and Region (2019-2025): The Advent of Technology with Respect to Mobile ECG is a Key Growth Driver - ResearchAndMarkets.com

Retrieved on: 
Friday, March 15, 2019

The global single lead ECG equipment market size is estimated to reach USD 487.59 million by 2025, progressing at a 4.72% CAGR during the forecast period.

Key Points: 
  • The global single lead ECG equipment market size is estimated to reach USD 487.59 million by 2025, progressing at a 4.72% CAGR during the forecast period.
  • Emergence of smartphone and mobile-based cardiac monitoring devices has been revolutionized the market in the past few years.
  • Medical device manufacturers continue to invest in development of these products in order to overcome pitfalls associated with conventional means of cardiac assessment.
  • Such advancements in ECG monitoring devices are anticipated to shape the future of the market over the forecast period.

The Global Implantable Cardiac Monitors Market size is expected to reach $714.4 Million by 2024, rising at a market growth of 7.6% CAGR during the forecast period

Retrieved on: 
Wednesday, March 13, 2019

NEW YORK, March 13, 2019 /PRNewswire/ -- The Global Implantable Cardiac Monitors Market size is expected to reach $714.4 Million by 2024, rising at a market growth of 7.6% CAGR during the forecast period.

Key Points: 
  • NEW YORK, March 13, 2019 /PRNewswire/ -- The Global Implantable Cardiac Monitors Market size is expected to reach $714.4 Million by 2024, rising at a market growth of 7.6% CAGR during the forecast period.
  • The implantable cardiac monitor, which is also referred to as implantable loop recorder, is a tiny insertable device used in continuously monitoring hearth rhythms.
  • Technological advancements in cardiac monitor devices such as miniaturization & easier implant procedures, growing demand for implantable cardiac monitors to continuously monitor heart to detect cardiac arrhythmias and atrial fibrillation are some of the key factors that are presently driving the implantable cardiac monitor's market growth.
  • Moreover, growing cases of cardiovascular diseases, remote monitoring systems and growing use of implantable cardiac monitors to monitor epilepsy disorder add to the growth of the market.

Bardy Diagnostics™ Announces Expansion into Canadian Market with Distributor JNC Medical

Retrieved on: 
Thursday, February 28, 2019

The agreement grants JNC Medical the right to distribute the BardyDxCarnation Ambulatory Monitor ("CAM"), the industry'sfirstP-wave centric ambulatory cardiac patch monitor and arrhythmia detection device, in the Canadian market.

Key Points: 
  • The agreement grants JNC Medical the right to distribute the BardyDxCarnation Ambulatory Monitor ("CAM"), the industry'sfirstP-wave centric ambulatory cardiac patch monitor and arrhythmia detection device, in the Canadian market.
  • "Thecollaboration with JNC Medical strengthens BardyDx's international distribution and business development initiatives, which are key prioritiesfor the Company this year," said Ken Nelson, BardyDx Chief Commercial Officer.
  • "Combining BardyDx's innovation and leadership in ambulatory cardiac monitoring with JNC Medical's Canadian market-specific expertise, distributionlogistics, anddeep connections with Canadian physicians will accelerate penetration of the CAM patch into the global market."
  • As part of its distribution strategy, JNC Medical intends to leverage its healthcare industry networks andphysician demands for extendedmonitoring, encouraginga transition to digital monitoring technologies.